Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

USANA HEALTH SCIENCES, INC.

(USNA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/18/2022 01/19/2022 01/20/2022 01/21/2022 01/24/2022 Date
99.05(c) 98.74(c) 98.58(c) 97.82(c) 99.19(c) Last
43 836 37 388 52 347 59 313 73 275 Volume
-2.17% -0.31% -0.16% -0.77% +1.40% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 1 191 M - -
Net income 2021 121 M - -
Net cash position 2021 226 M - -
P/E ratio 2021 16,6x
Yield 2021 -
Sales 2022 1 174 M - -
Net income 2022 110 M - -
Net cash position 2022 211 M - -
P/E ratio 2022 17,1x
Yield 2022 -
Capitalization 1 930 M 1 930 M -
EV / Sales 2021 1,43x
EV / Sales 2022 1,46x
Nbr of Employees 1 943
Free-Float -
More Financials
Company
USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, Foods, Personal Care and Skincare and All Other. Its USANA Nutritionals Optimizers product line consists of supplements designed to meet individual health and nutritional needs. Its Essentials/CellSentials product line includes... 
Sector
Food Processing
Calendar
02/08Earnings Release
More about the company
Ratings of USANA Health Sciences, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about USANA HEALTH SCIENCES, INC.
01/113 Surprising Benefits of National Stairs Day
AQ
01/06USANA Schedules Fourth Quarter and FY 2021 Earnings Release and Conference Call
BU
2021USANA Canada Takes Home Top DSA Awards
AQ
2021INSIDER SELL : Usana Health Sciences
MT
20214 Ways to Enhance Career in 2022
PR
2021USANA Assists Philippine Basketball Association As Nutritional Partner
PR
2021Use Power of Gratitude to Overcome Challenges
AQ
2021USANA honored with three prestigious awards
PR
2021USANA HEALTH SCIENCES INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
AQ
2021Investor Overview Q3 2021
PU
2021INSIDER SELL : Usana Health Sciences
MT
2021INSIDER SELL : Usana Health Sciences
MT
2021JOB ACTION DAY : Bestselling Author Shares Five Points to Improve Career
AQ
2021USANA Health Sciences to Seek Acquisitions
CI
2021USANA HEALTH : Q3 Earnings Snapshot
AQ
More news
News in other languages on USANA HEALTH SCIENCES, INC.
2021VENTE D'INITIÉS : Usana Health Sciences
2021VENTE D'INITIÉS : Usana Health Sciences
2021VENTE D'INITIÉS : Usana Health Sciences
2021USANA Health Sciences annonce une baisse de ses bénéfices au troisième trimestre de l'e..
2021ORIENTATION : (USNA) USANA HEALTH SCIENCES prévoit une fourchette de revenus pour 2021 de ..
More news
Analyst Recommendations on USANA HEALTH SCIENCES, INC.
More recommendations
Chart USANA HEALTH SCIENCES, INC.
Duration : Period :
USANA Health Sciences, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends USANA HEALTH SCIENCES, INC.
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 99,19 $
Average target price 104,00 $
Spread / Average Target 4,85%
EPS Revisions
Managers and Directors
Kevin G. Guest Chairman & Chief Executive Officer
Jim Brown President
G. Douglas Hekking Executive Vice President-Finance
Myron W. Wentz Chairman-Emeritus
Robert Andrew Sinnott Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
USANA HEALTH SCIENCES, INC.-3.34%1 930
BY-HEALTH CO., LTD.-3.75%6 970
BALCHEM CORPORATION-10.63%4 879
HERBALIFE NUTRITION LTD.6.38%4 447
THE SIMPLY GOOD FOODS COMPANY-13.54%3 629
MEDIFAST, INC.-6.70%2 261